Pharaoh Ant (Monomorium pharaonis): Newly Identified Important Inhalant Allergens in Bronchial Asthma by Kim, Cheol-Woo et al.
INTRODUCTION
Several studies indicate that insects are significant source of
aeroallergens (1-5). Although cockroaches have been exten-
sively studied, other insects have been rarely evaluated as a
source of indoor inhalant allergens (6-8). Changes of life style
and living environment have encouraged the growth of arthro-
pods including house dust mites (HDMs) and insects, and have
increased allergen exposure. Thus, recognition of unknown
avoidable allergens is an important part of clinical allergy prac-
tice.
The nonstinging house ant, Monomorium pharaonis (pharaoh
ant), is a highly infesting species in the urban indoor envi-
ronment. We recently identified that the pharaoh ant can
act as a source of aeroallergens (9). Despite of its possible role
in respiratory allergy, no detailed study has been performed
whether pharaoh ant represents an important source of inhalant
allergens. We performed this study to evaluate type I hyper-
sensitivity to pharaoh ant and its clinical significance in res-
piratory allergy. This is the first study in which large num-
ber of patients with bronchial asthma was evaluated for sen-
sitization to pharaoh ant, and for clinical and immunologic
characteristics of pharaoh ant allergy. 
MATERIALS AND METHODS
Study subjects
A total of 318 young and middle-aged adult patients with
bronchial asthma aged from 15 to 50 yr (mean 30.8 yr, 192
males, 126 females) who visited Allergy Clinic of Yonsei Uni-
versity Severance Hospital between January 2001 and Decem-
ber 2002 were enrolled in this study. Asthma was diagnosed
if patient with typical symptoms of asthma showed either
reversible airflow limitations defined as improvement of FEV1
of more than 15% after inhalation of 200  g of salbutamol,
and/or airway hyperresponsiveness to methacholine. Steroid-
dependent asthmatics or patients with associated cardio-pul-
monary disorders were excluded in the present study. Ten
healthy subjects (6 males, 4 females) with no personal or fami-
ly history of allergic disorders were also studied as controls. 
Preparation of pharaoh ant extract
Pharaoh ants were collected from the patients’ houses, and
their species were confirmed by Professor B. J. Kim (Won-
kwang University, Iksan, Korea). They were ground up and
extracted into phosphate-buffered saline solution (PBS, pH
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Pharaoh Ant (Monomorium pharaonis): Newly Identified Important
Inhalant Allergens in Bronchial Asthma
The nonstinging house ant, Monomorium pharaonis (pharaoh ant), was recently
identified as a cause of respiratory allergy. This study was performed to evaluate
the extent of sensitization to pharaoh ant, and its clinical significance in asthmatic
patients. We carried out skin prick tests in 318 patients with asthma. Specific IgE
(sIgE) to pharaoh ant was measured by ELISA, and cross-reactivity was evaluat-
ed by ELISA inhibition tests. Bronchial provocation testing was performed using
pharaoh ant extracts. Fifty-eight (18.2%) of 318 patients showed positive skin
responses to pharaoh ant, and 25 (7.9%) had an isolated response to pharaoh ant.
Positive skin responses to pharaoh ant were significantly higher among patients
with non-atopic asthma than among those with atopic asthma (26.0% vs. 14.9%,
p<0.05). There was significant correlation between sIgE level and skin responses
to pharaoh ant (rho=0.552, p<0.001). The ELISA inhibition tests indicated that
pharaoh ant allergens had various pattern of cross-reactivity to house dust mites
and cockroaches. Bronchial provocation tests to pharaoh ant were conducted for
9 patients, and eight showed typical asthmatic reactions. In conclusion, pharaoh ant
is an important source of aeroallergens, and it should be included in the skin test
battery for screening the causative allergens in patients with asthma.
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7.4) 1:20 w/v at 4℃ for 48 hr, followed by centrifugation at
12,000 rpm for 1 hr. The supernatant was dialyzed against
distilled water at 4℃for 48 hr and then used as crude extract.
The protein concentration of the extract was 500.3 g/mL,
as determined using the BioRad method. For skin prick test-
ing, the extract was diluted with PBS and then mixed with
an equal amount of sterile glycerin (final concentration of
1:100 w/v).
Allergy skin prick test
Skin prick tests were performed using 1 mg/mL histamine
as a positive control, the diluent as a negative control, pharaoh
ant extract (1:100 w/v), imported fire ant (IFA) extract (Hol-
lister-Stier Laboratories LLC, Spokane, WA, U.S.A.), and 30
common aeroallergens including pollens, molds, animal dan-
ders, cockroaches, Dermatophagoides farinae, and Dermatopha-
goides pteronyssinus (AT Ltd, Worthing, West Sussex, U.K.).
After 15 min, the mean diameter of the wheal formed by the
allergen was compared with that formed by histamine. If the
former was the same or larger than the latter (A/H ratio ≥1),
it was considered positive. Atopy was defined as positive skin
response to one or more inhalant allergens among 30 common
aeroallergens.
Specific IgE determination and cross-reactivity study
The presence of specific IgE (sIgE) to pharaoh ant was deter-
mined by using the ELISA according to the method described
previously (9). Microtiter plates were coated with 50 L of
0.05 M carbonate buffer (pH 9.6) containing 10 g/mL of
pharaoh ant extract at 4℃. After blocking, the plate was
incubated with 50 L of either patient or control sera (undi-
luted) from 10 healthy volunteers with negative skin prick
test responses to common aeroallergens as well as to pharaoh
ant. After washing, the plate was incubated with 50 L of
biotinylated anti-human IgE (Vector Laboratories, Burlingame,
CA, U.S.A.) followed by incubation with streptavidin-per-
oxidase (Sigma-Aldrich Corp, St Louis, MO, U.S.A.). After
washing, 100 L of ABTS solution (25 mg 2,2′ -azino-bis-3-
ethylbenzthiazoline-sulfonic acid in 50 mL of 50 mM citrate
phosphate buffer containing 50 L of 0.03% hydrogen per-
oxide) was added as a substrate, and after 5 min 100 L of 2
mM NaN3was added to stop the reaction. A colorimetric reac-
tion was measured by the absorbance at 405 nm on an ELISA
reader (Dyna-tec, Alexandria, CA, U.S.A.). The positive cut-
off value was decided as mean +2×SD of the absorbance
value of the healthy control serum samples.
To determine the specificity of the IgE binding and the
allergenic cross-reactivity, ELISA inhibition tests were per-
formed. The patient’s undiluted serum was preincubated with
inhibitors such as IFA (Bayer, Pittsburgh, PA, U.S.A.), Pachy-
condyla chinensis, Blattella germanica, and D. farinae extracts
(supplied from Korea National Research Resource Collec-
tion of Allergens, Seoul, Korea), and then added to a pharaoh
ant antigen-coated immunoplate. The same steps were fol-
lowed as in the ELISA.
Bronchial provocation test
In order to evaluate the specificity of sIgE response to pha-
raoh ant, specific bronchial provocation tests (BPTs) were per-
formed according to the method previously described (9).
Briefly, patients inhaled the aerosolized extract dissolved in
0.4% phenol/0.9% saline for 2 min by using the tidal breath-
ing method. A control challenge with phenol-saline was per-
formed before antigen provocation, and then serial increments
of ant extracts (from 1:100,000 to 1:1,000 w/v) were adminis-
tered at 10-min intervals until a 20% or greater decrease in
FEV1 was obtained or until the highest concentration of the
extract was inhaled. Both FEV1and FVC were measured every
10 min during the first hour, and then every hour for the
remaining 7 hr after the challenge. 
Statistical analysis
Statistical analysis was performed using the chi-square tests,
and Student’s t-tests to assess differences between positive
skin responders and negative responders. Spearman’s rank
correlation was calculated to assess the correlation between
data. A p-value of 0.05 or less was regarded as significant.
RESULTS
Skin prick tests and clinical characteristics of patients
A total of 222 out of 318 patients showed positive respons-
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es to one or more inhalant allergens, and the rate of atopic
asthma was 69.8% in this study. Fig. 1 shows skin prick test
responses to common inhalant allergens and pharaoh ant. D.
farinae was the most common sensitizing allergen (52.8%),
followed by D. pteronyssinus (52.5%), cockroach (27.4%),
and cat (19.8%). Among the 318 enrolled patients, 58 (18.2
%) elicited a positive reaction to pharaoh ant, and skin sensi-
tization to pharaoh ant was much higher than to other impor-
tant aeroallergens in Korea (dog 15.1%, mugwort pollen
11.3%, ragweed pollen 8.5%, birch pollen 5.7%, etc). Skin
prick test revealed that 25 (7.9%) had an isolated positive res-
ponse to pharaoh ant with negative results to other common
aeroallergens in their environment. The positive skin respons-
es to pharaoh ant were significantly higher among patients
with non-atopic asthma (25 of 96, 26.0%) than among those
with atopic asthma (33 of 222, 14.9%) (p=0.018).
Table 1 shows the clinical characteristics of the patients
according to skin responses to pharaoh ant. No significant
difference of age, sex, level of total IgE, and degree of airway
hyperresponsiveness to methacholine was noted between posi-
tive skin responders and negative responders to pharaoh ant.
The positive skin responses to house dust mites, cockroach,
cat, mugwort, and other common aeroallergens were not
higher among subjects with positive responders than among
those with negative responders to pharaoh ant. Despite high-
er tendency of sensitization to IFAs in subjects with positive
responders, no statistical significance of positive skin responses
to IFAs was noted between positive responders and negative
responders to pharaoh ant.
Specific IgE determination and ELISA inhibition study
Levels of sIgE to pharaoh ant were measured with sera of
the 58 patients with positive skin response to pharaoh ant,
50 randomly selected patients with negative skin response
to pharaoh ant, and 10 controls by using ELISA method. Fifty
(86.2%) of the 58 patients with positive skin responders had
significant level of sIgE to pharaoh ant, on the other hand,
5 (10%) of 50 negative skin responders had sIgE. None of
the controls gave a positive sIgE to pharaoh ant (Fig. 2). Thus
50 (15.7%) of 318 enrolled patients showed both positive
skin test reactions and sIgE antibodies to pharaoh ant. A sig-
nificant correlation was noted between levels of sIgE and skin
responses (allergen/histamine ratio) to pharaoh ant (rho=0.552,
p<0.001, Fig. 3) in patients with positive skin responders.
To determine the allergenic cross-reactivity of pharaoh ant,
we performed ELISA inhibition tests with sera of patients
Log-IgE, the logarithmically transformed value of serum total IgE; Log-
PC20, the logarithmically transformed provocative concentration of
methacholine resulting in 20% fall in FEV1.
Positive Negative
p value
Skin response to pharaoh ant
Number 58 260
Age (yr, mean±SD) 30.6±10.0 30.9±9.20 >0.05
Sex (male/female) 33/25 159/101 >0.05
Log-IgE (IU/mL, mean±SD) 2.25±0.60 2.37±0.64 >0.05
Log-PC20 (mg/mL, mean±SD) 0.11±0.79 0.09±0.86 >0.05
Positive skin responses to
D. farinae (%) 29 (50.0%) 139 (53.5%) >0.05
D. pteronyssinus (%) 28 (48.3%) 139 (53.5%) >0.05
Cockroach (%) 22 (37.9%) 165 (25.0%) >0.05
Cat (%) 14 (24.1%) 149 (18.8%) >0.05
Mugwort pollen (%) 10 (17.2%) 126 (10.0%) >0.05
Improted fire ant (%) 12 (20.7%) 30 (9.4%) >0.05
Table 1. Characteristic of the patients according to skin respons-
es to pharaoh ant
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with high sIgE to pharaoh ant. In many patients, the results
of ELISA inhibition testing indicate that sIgE binding to
pharaoh ant was completely inhibited by pharaoh ant, par-
tially inhibited by IFA antigen, but not inhibited by P. chi-
nensis, B. germanica, and D. farinae extract (Fig. 4A). On the
other hand, some patients showed different pattern of cross-
reactivity; IgE binding to pharaoh ant was partially inhibit-
ed by B. germanica, and D. farinae extract, but not by P. chi-
nensis (Fig. 4B).
Bronchial provocation test and clinical characteristics of
pharaoh ant-sensitive asthma
BPTs were performed on 9 patients living in a home with
visual evidence of ant infestation with positive skin reaction
and high sIgE to pharaoh ant. Of them, 8 patients showed
typical pattern of asthmatic reactions (4 showed isolated early
asthmatic reactions, 4 dual asthmatic reactions). These 8
patients were considered as having pharaoh ant-allergic asth-
ma based on their environmental characteristics, positive skin
test and sIgE, and positive response to BPTs with pharaoh
ant extract. BPTs with pharaoh ant extract were also per-
formed on 5 patients with negative skin testing and sIgE
response, but no significant change in FEV1 was noted.  
Table 2 shows the clinical characteristics of patients with
pharaoh ant-sensitive asthma. All had lived in urban areas
and experienced asthmatic symptoms as well as recurrent
nasal symptoms. Four patients (No. 1, 3, 5, and 6 in Table
2) were housewives and spent plenty of time in their home,
and remain four were students spending a lot of time in their
homes or schools. None had any pet or household mold prob-
lems at their homes, and had known history of ant sting or
bite injury. On skin prick test, 4 had an isolated positive res-
ponse to pharaoh ant with negative results to common aeroal-
skin response, skin response to pharaoh ant; A/H, wheal size formed by pharaoh ant/histamine; sIgE, pharaoh ant-specific IgE, levels are described
as absorbance value in ELISA; BPT, pharaoh ant-specific bronchial provocation test; PC20, provocative concentration of methacholine resulting in
20% fall in FEV1; Early, early asthmatic reaction; Dual, dual asthmatic reaction; Oak, oak pollen; Birch, birch pollen.
Patient Sex Total IgE (IU/mL) PC20 (mg/mL) Skin response (A/H, mm) BPT response
sIgE
(absorbance)
Age
(yr)
Skin response to common
allergen (mm)
1 F 45 80 5.3 10/3 0.979 Early Negative
2 M 18 740 1.79 10/4 0.879 Dual Cockroach 10, Cat 7
3 F 40 270 0.59 7/3 0.569 Dual Dog 3, cat 3
4 F 17 320 0.09 10/3 0.471 Dual Negative
5 F 35 470 0.08 4/3 0.445 Early Oak 8, Birch 6
6 F 49 145 0.59 9/4 0.374 Early Negative
7 M 22 152 0.63 11/4 0.207 Early Cockroach 4
8 M 20 120 1.72 6/3 0.198 Dual Negative
Table 2. Clinical features of the patients with pharaoh ant-sensitive asthma
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Fig. 4. Enzyme-linked immunosorbent assay inhibition of pharaoh ant specific IgE. Individual serum samples were preincubated with inhi-
bitors [pharaoh ant (   ), imported fire ant (   ), P. chinensis (   ), D. farinae (   ), B. germanica (   )] and then added to a pharaoh ant-coat-
ed immunoplate. Specific IgE binding to pharaoh ant is inhibited by pharaoh ant, but not by P. chinensis, B. germanica, and D. farinae
extract (A). Serum from some patients showed different pattern of cross-reactivity; specific IgE binding is partially inhibited by B. germani-
ca, and D. farinae extract, but not by P. chinensis (B). 
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lergens. All patients were recommended to eradicate ant infes-
tation at their homes by measures such as restricting access,
chemical control, and traps. Treatment with such environ-
mental control and pharmacological treatment led progres-
sive improvement of symptoms in all patients. 
DISCUSSION
Development of immunochemical assay can measure var-
ious air-borne allergens irrespective of their morphological
features. Using various techniques, insect-related particles
of less than 10  m in size have been demonstrated in the air
or dust samples (10-12). Therefore, the significance of insects
as a source of inhalant allergens has been widely accepted.
Several studies have reported that many kinds of insects includ-
ing locusts, crickets, moths, houseflies can cause respiratory
sensitization, but the clinical significance of IgE to these insects
remains obscure owing to lack of clinical correlation (2-5).
Furthermore insects other than cockroaches have been rarely
evaluated as a source of indoor aeroallergens (6-8). We recent-
ly reported that the nonstinging house ant, pharaoh ant, can
act as an indoor source of inhalant allergens (9). To eliminate
possible confounding factors, old patients with asthma were
excluded and only young and middle-aged adults with asthma
were included in this study. It was found that many patients
with asthma have sIgE response to pharaoh, and some patients
selected for BPTs showed typical asthmatic reactions after
inhalant exposure to pharaoh ant antigens. These results indi-
cated that pharaoh ant is an important source of indoor in-
halant allergens. This is the first study that the clinical sig-
nificance of pharaoh ant was evaluated in large number of
patients with asthma.  
The ant is a widespread insect that comprises 11 subfami-
lies, 297 genera, and approximately 8,800 species (13). In
Korea 4 subfamilies, 33 genera, and 104 species of ants have
been registered, and the 4 subfamilies include the Formici-
nae, the Myrmicinae, the Ponerinae, and the Dolichoderinae
(14). Pharaoh ant, the tiny yellow ant belonging to the Myr-
micinae subfamily and the Formicidae family, is of tropical
origin and do not nest out of doors except in southern lati-
tudes (Fig. 5). It has become a seriously troublesome insect
in indoor environment, and its infestation has continuously
increased because of its ability to disperse (13, 14). In recent-
ly performed our field survey, it was found that pharaoh ant
infests in about 20% of homes in Seoul, Korea (unpublished
data).
There is little data on the prevalence of sensitization to
ant. Lierl et al. screened children with allergic asthma by
RAST for sIgE directed against outdoor insects, and found
prevalence of sensitization to ant up to 12.9% (1). Although
they did not clearly state the scientific name of the ant, they
used outdoor ant. In current outdoor environment, it is diffi-
cult that particles derived from non-flying outdoor ant can be
airborne enough to be exposed to human via respiratory route.
Moreover, about 20% of adults living in a fire ant endemic
area showed positive skin response and sIgE to fire ant, debat-
ing on the significance of the presence of sIgE to outdoor ant
in population (15). The clinical meaning of sIgE to ant in pre-
vious study remains more and more uncertain because many
of the subjects reacted with more than one insect species, im-
plying extensive cross-sensitization (1). There is good evi-
dence that pan-allergens like tropomyosin are responsible for
this multiple reactivity (16, 17).
However, pharaoh ant in this study is indoor ant, and pha-
raoh ant-derived particles such as shed scale, excreta, and dis-
integrated bodies are more easily accumulated in environmen-
tal reservoirs and exposed to human in indoor environment
than in outdoor environment. Some patients in this study
had an isolated positive response to pharaoh ant with nega-
tive results to other aeroallergens, and this result also suggests
that response to pharaoh ant represent not cross-reactive but
specific responses. The results of ELISA inhibition tests show-
ing complete inhibition of IgE binding by pharaoh ant itself
but not by other indoor allergens indicate that sIgE response
to pharaoh ant is specific. A concept of insect pan-allergy is
opposed by reports similar to the present one suggesting that
sensitization may be more specific in patients with insect
allergy (5, 18). After considering all these findings, we strong-
ly suggest that pharaoh ant allergens have unique allergenic
determinants, and elicit sIgE-mediated immune reactions.
Allergen sensitization is known to occur at a higher rate
among atopic individuals (19, 20). In this study, positive skin
responses to common aeroallergens such as HDMs, cockroach-
es, animal dander, and pollens were not different between sub-
jects sensitized to pharaoh ant and those not sensitized. This
finding suggest that sensitization to pharaoh ant is influenced
by factors other than genetic predisposition to atopy alone.
Some environmental factors may affect sensitization to pharaoh
ant. However we did not get detailed information on home
environment such as family size, housing type, location of
Fig. 5. Monomorium pharaonis (Linne) worker ranging size from
1.5 to 2.5 mmPharaoh Ant: Newly Identified Inhalant Allergens  395
home, presence of ant infestation or pet, and so on from indi-
vidual subject. Thus it is not known which environmental
factors may affect sensitization to pharaoh ant, and further
study may be required for this important issue. 
The recognition of allergic sensitizations may determine
the prognosis and treatment of asthma. Detection of remov-
able sources of allergens is particularly significant in clinical
practice. Some patients diagnosed as having non-atopic asth-
ma may be sensitized to unknown allergens. In this study, a
quarter of adult patients with non-atopic asthma were, in fact,
sensitized to pharaoh ant. We strongly suggest that pharaoh
ant allergens should be included in skin test batteries of com-
mon inhalant allergens for screening the causative allergens
in patients with asthma.
Although recent consensus reports stress the importance
of environmental control for allergen, the clinical benefit of
allergen avoidance is still controversial. Effect of allergen avoid-
ance in adults is more complicated by several factors such as
presence of chronic obstructive pulmonary disease, effect of
smoking and pollutants, and the problem of airway remod-
eling (21). Although occupational asthma is frequently used
as a model explaining the association between cessation of
exposure and asthma prognosis, delayed diagnosis and sub-
sequent irreversibility of occupational asthma may lead to
falsely unfavorable outcomes. We already reported two cases
of pharaoh ant-sensitive asthma who showed remission of
asthma and negative conversion of airway hyperresponsive-
ness after allergen avoidance (9). We think that pharaoh ant-
sensitive asthma is a good model for the study of the allergen
avoidance. Therefore further longitudinal studies will clear-
ly demonstrate the benefit of allergen avoidance on patients
with bronchial asthma.  
The high frequency of skin reactivity along with the results
of sIgE ELISA and BPT in this study suggest that the pharaoh
ant-derived particles possess potent allergenic components
and are present in the indoor environment in sufficient quan-
tities and for a sufficient time to cause sensitization. In con-
clusion, pharaoh ant is an important indoor source of inhalant
allergens among patients with asthma living in urban areas,
and pharaoh ant allergens have unique allergenic determi-
nants. These species should be taken into consideration as a
cause of asthma in patients living in urban areas, especially
in homes with visual evidence of ant infestation.
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